Atrinsic Inc. (PTIX) vs Silexion Therapeutics Corp (SLXN)

Atrinsic Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Silexion Therapeutics Corp is the larger, with a market value of $1.4M against $1.3M — 1.1× the size. Silexion Therapeutics Corp has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.3×. Across the 9 metrics below, Atrinsic Inc. leads on 6 and Silexion Therapeutics Corp on 3.

Valuation

Metric PTIX SLXN Biotechnology median
P/E 0.35 n/m 7.88
P/S n/m n/m 11.47
P/B 0.82 4.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.04 0.74
EV/Sales n/m n/m 10.73
Earnings yield 285.90% (8,359.54%) (28.84%)
Free cash flow yield (152.63%) (6,963.95%) (23.03%)

Profitability

Metric PTIX SLXN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (338.24%) (17,021.95%) (57.72%)
Return on assets 390.69% (277.96%) (49.22%)
Return on invested capital (229.86%) 0.00% 0.00%

Growth

Metric PTIX SLXN Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 188.24% 97.73% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTIX SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.66 0.94 4.73
Net debt to EBITDA 0.52 0.38 0.96

Dividend

Metric PTIX SLXN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PTIX SLXN Biotechnology median
Market cap 1.27m 1.44m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack